// App-Quantinova.ai

TCT-765 : Effect of PSP and other Elements of Technique on 3 Year Outcomes Among Metallic Everolimus-Eluting Stent-Treated Patients in the ABSORB Trials

Researchers

Presenter

  • Stephen Ellis

Principal Investigators

  • Dean Kereiakes

  • Patrick Serruys

  • Yoshinobu Onuma

  • Takeshi Kimura

  • Runlin Gao

  • Ovidiu Dressler

  • Thomas McAndrew

  • Gregg Stone

Medical Centers

  • CLEVELAND CLINIC, CLEVELAND, OH, United States,

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Imperial College, London, United Kingdom

  • The Christ Hospital, Cincinnati, Ohio, United States

  • Cardiovascular Research Foundation, New York, New York, United States

  • Kyoto University Graduate School of Medicine, Kyoto, Japan

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China, Beijing, Beijing, China

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

Locations

  • United States

  • Netherlands

  • United Kingdom

  • Japan

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Regenerating islet-derived 1 alpha

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved